Pain control in patients with cancer

European Journal of Cancer Part A

Volumn 33, Issue SUPPL. 4, 1997, Pages

  Ahmedzai, S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Analgesia; Cancer; Caregiver; Malignancy; Metastasis; Opioid; Pain; Palliative care; Pharmacotherapy; Quality of life

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANTICONVULSIVE AGENT; CALCITONIN; CARBAMAZEPINE; CLODRONIC ACID; CLONAZEPAM; CLONIDINE; CORTICOSTEROID; DESIPRAMINE; DEXAMETHASONE; KETAMINE; LOCAL ANESTHETIC AGENT; METHYLPREDNISOLONE; MEXILETINE; MORCAPS; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE AGONIST; PAMIDRONIC ACID; PHENYTOIN; PREDNISONE; SCOPOLAMINE BUTYL BROMIDE; STRONTIUM; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ANALGESIA; BONE PAIN; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED DRUG RELEASE; DRUG INDICATION; EPIDURAL DRUG ADMINISTRATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RECTAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; SYNCOPE; TRANSDERMAL DRUG ADMINISTRATION; VOMITING;

EID: 0030750213     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00149-4     Document Type: Conference Paper

References (43)

1. Niles R. Pharmacologic management of cancer pain. Nurs Clin North Am 1995, 30, 745-763.
2. Grossman SA, Staats PS. Current management of pain in patients with cancer. Oncolog 1994, 8, 93-107.
3. MacDonald N. A proposed matrix for organisational changes to improve quality of life in oncology. Eur J Cancer 1995, 31A(Suppl. 6), S18-S21.
4. Expert Working Group of the European Association for Palliative Care. Morphine in cancer pain: modes of administration. Br Med J 1996, 312, 823-826.
5. Larue F, Colleau SM, Brasseur L, Cleeland CS. Multicentre study of cancer pain and its treatment in France. Br Med J 1995, 310, 1034-1037.
6. Portenoy RK. Pharmacologic management of cancer pain. Semin Oncol 1995, 22(2 Suppl. 3), 112-120.
7. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA 1995, 274, 1874-1880.
8. Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer 1982, 50, 1913-1918.
9. Foley KM. Pain syndromes in patients with cancer. In Bonica JJ, Ventafridda V, eds. Advances in Pain Research and Therapy, Vol 2. New York, Raven Press, 1979, 59-75.
10. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995, 63, 65-76.
11. Brooks DJ, Gamble W, Ahmedzai S. A regional survey of opioid use by patients receiving specialist palliative care. Palliat Med 1995, 9, 229-238.
12. Ahmedzai S. Making a success out of life's failure (editorial). Prog Palliat Care 1996, 4, 1-3.
13. Foley KM. The treatment of cancer pain. N Engl J Med 1985, 313, 84-95.
14. Twycross R. Pain. In Twycross R, ed. Introducing Palliative Care. Oxford, Radcliffe Medical Press, 1995, 72.
15. World Health Organization. Cancer Pain Relief and Palliative Care. Report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization, 1990. Technical report series 804.
16. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management: stepping up the quality of its evaluation. JAMA 1995, 274, 1870-1873.
17. Hudzinski DM. An algorithmic approach to cancer pain management. Nurs Clin North Am 1995, 30, 711-723.
18. Hill CS Jr. When will adequate pain treatment be the norm? JAMA 1995, 274, 1881-1882.
19. Rousseau P. Do terminally ill patients receive adequate pain management? Drugs Aging 1996, 8, 233-236.
20. Olsen AK, Sjøgren P. Neurotoxic effects of opioids. Eur J Palliat Care 1996, 3, 139-142.
21. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Management 1995, 10, 287-291.
22. de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Management 1995, 10, 378-384.
23. Broomhead AF, Kerr O, Tester WJ, Bowles RL, Maccarrone C, Hodsman GP. Kadian™/Kapanol™ - a once daily morphine formulation (abstract). Eur J Cancer 1995, 31A, S182.
24. Gourlay GK, Plummer JL, Cherry DA. Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution. Pain 1995, 61, 375-381.
25. Chrubasik J, Wüst H, Friedrich G, Geller E. Absorption and bioavailability of nebulized morphine. Br J Anaesth 1988, 61, 228-230.
26. Masood AR, Reed JW, Thomas SHL. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax 1995, 50, 629-634.
27. Ahmedzai S. Palliation of respiratory symptoms. In Doyle D, Hanks G, MacDonald N, eds. Oxford Textbook of Palliative Medicine. Oxford, Oxford Medical Publications 1993, 349-378.
28. Warren DE. Practical use of rectal medications in palliative care. J Pain Sympt Management 1996, 11, 378-387.
29. Ahmedzai S, Brooks DJ. Transdermal fentanyl versus sustained release oral morphine in cancer pain: preference, efficacy and quality of life. J Pain Symptom Management, in press.
30. Coleman R, Purohit K, Vinholes J. New roles for bisphosphonates in cancer therapy. Progress Palliat Care 1996, 4, 39-43.
31. Delmas PD. Bisphosphonates in treatment of bone diseases. N Engl J Med 1996, 335, 1836.
32. Purohit OP, Anthony C, Radstone CR, Owen J, Coleman RE. High-dose intravenous pamidronate for metastatic bone pain. Br J Cancer 1994, 70, 554-558.
33. Hortobagyi GN, Theriault RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lyric bone metastases. N Engl J Med 1996, 335, 1785-1791.
34. Lewington VJ, McEwan AJ, Ackery DM, et al. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 1991, 27, 954-958.
35. Anon. Endoprostheses for bony metastases (letter). Lancet 1992, 339, 1145.
36. Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth 1996, 77, 441-444.
37. Mercadante S. Ketamine in cancer pain: an update. Palliat Med 1996, 10, 225-230.
38. Luczak J, Dickenson AH, Kotlinska-Lemieszek A. The role of ketamine, an NMDA receptor antagonist, in the management of pain. Prog Palliat Care 1995, 3, 127-134.
39. Dohl S. Spinal antinociception. Curr Opin Anaesth 1996, 9, 404-409.
40. Wood PEA, Rushby C, Ahmedzai S. Epidural steroid injections for malignant pain. J Cancer Care 1992, 1, 139-144.
41. Ahmedzai S, Brooks D. Pain control in palliative care. Hosp Update, 1994, 549-554.
42. Berger SM. Pain control in palliative care (letter). Hosp Update, 1995, 42.
43. Ahmedzai S. Recent clinical trials of pain control: impact on quality of life. Eur J Cancer 1995, 31A(Suppl 6), S2-S7.